Evidence map›Paper›PMID 41439091›Full record

ArticleCureus2025

Psoriatic Arthritis Features and Risk of Cardiovascular Events: A Nationwide Cohort Study.

Roel Sanchez Baez, Arthur Kavanaugh, Monica Guma, Joel M Kremer, George Reed

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Roel Sanchez BaezDepartment of Medicine, University of California San Diego, La Jolla, USA.
Arthur KavanaughDepartment of Medicine, University of California San Diego, La Jolla, USA.
Monica GumaDepartment of Medicine, University of California San Diego, La Jolla, USA.
Joel M KremerDepartment of Medicine, Corrona Research Foundation, Delray Beach, USA.
George ReedDepartment of Medicine, University of Massachusetts, Worcester, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aimed to assess the specific clinical features of psoriatic arthritis as predictors of cardiovascular (CV) risk.

methodsData were drawn from the CorEvitas observational US registry database of 5,131 patients with psoriatic arthritis. Out of these, 3,696 were included because they had no history of a CV event and had at least one follow-up visit. Participant characteristics were assessed at baseline visits, and participants were tracked until their last follow-up visit or the occurrence of a CV event. The mean tracked follow-up time was 3.69 years (SD ±2.87). Dactylitis and enthesitis were designated as the primary predictors of CV events. Secondary predictors were tender and swollen joint counts, nail involvement, and psoriasis body surface area percentage. Baseline characteristics were compared between those with dactylitis vs. those without and those with enthesitis vs. those without, using Fisher's exact test for categorical variables and the Kruskal-Wallis test for continuous variables. Unadjusted Kaplan-Meier curves were estimated. Cox regression models estimated CV risk (hazard ratios).  Results and conclusion: No statistically significant association between designated predictors and the development of CV events was observed. Dactylitis was more prevalent in the group with enthesitis than in the group without enthesitis (p<0.001). Enthesitis was also more prevalent in the group with dactylitis than in the group without dactylitis (p<0.001). Numbers of tender and swollen joints were significantly increased both with dactylitis and enthesitis (p<0.001 for all four analyses). Our results contrast with prior studies reporting associations of dactylitis with CV events and enthesitis with CV risk.

Indexed as

cardiovascular riskdactylitisenthesitismajor adverse cardiovascular events (mace)psoriatic arthritis (psa)

Identifiers

PMID41439091
PMCPMC12719533

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.